Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using <sup>1</sup>H HR‐MAS spectroscopy of biopsy tissues
May‐Britt Tessem(University of California, San Francisco), John Kurhanewicz(University of California, San Francisco)
Cited by 204
Related Papers
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology
|Neoplasia|2018|444
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
|British Journal of Cancer|2015|109